HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Research | Clinical Cancer Research |
Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 10 1105-1114, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
WK Kaufmann, JL Schwartz, JC Hurt, LL Byrd, DA Galloway, E Levedakou and RS Paules
Department of Pathology and Laboratory Medicine, and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 27599-7295, USA.
Chromosomal stability was linked to G2 checkpoint function in human fibroblasts expressing the human papillomavirus type 16 E6 oncoprotein. Soon after expression of E6, cells displayed an undamaged, diploid karyotype and normal mitotic delay after gamma-irradiation. As the E6-expressing cells aged through their in vitro life span, G2 checkpoint function diminished progressively. After 30-70 population doublings, 60-86% of the E6 cells displayed defective G2 checkpoint response. This attenuation of G2 checkpoint function was also associated with radiation-resistant cyclin B1/CDK1 protein kinase activity. Numerical and structural abnormalities of chromosomes developed in unirradiated E6 cells with kinetics that mirrored the loss of G2 checkpoint function. A significant correlation between inactivation of the G2 checkpoint and acquisition of chromosomal abnormalities was found, suggesting that the G2 checkpoint represents a barrier to genetic instability in cells lacking G1 checkpoint function.
This article has been cited by other articles:
![]() |
![]() |
![]() |
![]() |
![]() ![]() T. Zhou, J. Chou, Y. Zhou, D. A. Simpson, F. Cao, P. R. Bushel, R. S. Paules, and W. K. Kaufmann Ataxia Telangiectasia-Mutated Dependent DNA Damage Checkpoint Functions Regulate Gene Expression in Human Fibroblasts Mol. Cancer Res., August 1, 2007; 5(8): 813 - 822. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() C. L. Innes, A. N. Heinloth, K. G. Flores, S. O. Sieber, P. B. Deming, P. R. Bushel, W. K. Kaufmann, and R. S. Paules ATM Requirement in Gene Expression Responses to Ionizing Radiation in Human Lymphoblasts and Fibroblasts Mol. Cancer Res., March 1, 2006; 4(3): 197 - 207. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() E. G. Mimnaugh, W. Xu, M. Vos, X. Yuan, J. S. Isaacs, K. S. Bisht, D. Gius, and L. Neckers Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity Mol. Cancer Ther., May 1, 2004; 3(5): 551 - 566. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() K. S. Bisht, C. M. Bradbury, D. Mattson, A. Kaushal, A. Sowers, S. Markovina, K. L. Ortiz, L. K. Sieck, J. S. Isaacs, M. W. Brechbiel, et al. Geldanamycin and 17-Allylamino-17-demethoxygeldanamycin Potentiate the in Vitro and in Vivo Radiation Response of Cervical Tumor Cells via the Heat Shock Protein 90-Mediated Intracellular Signaling and Cytotoxicity Cancer Res., December 15, 2003; 63(24): 8984 - 8995. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() A. Mauser, E. Holley-Guthrie, A. Zanation, W. Yarborough, W. Kaufmann, A. Klingelhutz, W. T. Seaman, and S. Kenney The Epstein-Barr Virus Immediate-Early Protein BZLF1 Induces Expression of E2F-1 and Other Proteins Involved in Cell Cycle Progression in Primary Keratinocytes and Gastric Carcinoma Cells J. Virol., December 15, 2002; 76(24): 12543 - 12552. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() P. B. Deming, K. G. Flores, C. S. Downes, R. S. Paules, and W. K. Kaufmann ATR Enforces the Topoisomerase II-dependent G2 Checkpoint through Inhibition of Plk1 Kinase J. Biol. Chem., September 27, 2002; 277(39): 36832 - 36838. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() H. Konishi, T. Nakagawa, T. Harano, K. Mizuno, H. Saito, A. Masuda, H. Matsuda, H. Osada, and T. Takahashi Identification of Frequent G2 Checkpoint Impairment and a Homozygous Deletion of 14-3-3{epsilon} at 17p13.3 in Small Cell Lung Cancers Cancer Res., January 1, 2002; 62(1): 271 - 276. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() P. B. Deming, C. A. Cistulli, H. Zhao, P. R. Graves, H. Piwnica-Worms, R. S. Paules, C. S. Downes, and W. K. Kaufmann The human decatenation checkpoint PNAS, October 9, 2001; 98(21): 12044 - 12049. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() R. E. Shackelford, C. L. Innes, S. O. Sieber, A. N. Heinloth, S. A. Leadon, and R. S. Paules The Ataxia telangiectasia Gene Product Is Required for Oxidative Stress-induced G1 and G2Checkpoint Function in Human Fibroblasts J. Biol. Chem., June 15, 2001; 276(24): 21951 - 21959. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() P. M. Flatt, L. J. Tang, C. D. Scatena, S. T. Szak, and J. A. Pietenpol p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent Mol. Cell. Biol., June 15, 2000; 20(12): 4210 - 4223. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() C. A. Smith, A. A. Pollice, L.-P. Gu, K. A. Brown, S. G. Singh, L. E. Janocko, R. Johnson, T. Julian, D. Hyams, N. Wolmark, et al. Correlations Among p53, Her-2/neu, and ras Overexpression and Aneuploidy by Multiparameter Flow Cytometry in Human Breast Cancer: Evidence for a Common Phenotypic Evolutionary Pattern in Infiltrating Ductal Carcinomas Clin. Cancer Res., January 1, 2000; 6(1): 112 - 126. [Abstract] [Full Text] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() T. M. Passalaris, J. A. Benanti, L. Gewin, T. Kiyono, and D. A. Galloway The G2 Checkpoint Is Maintained by Redundant Pathways Mol. Cell. Biol., September 1, 1999; 19(9): 5872 - 5881. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() J. J. Swenson, A. E. Mauser, W. K. Kaufmann, and S. C. Kenney The Epstein-Barr Virus Protein BRLF1 Activates S Phase Entry through E2F1 Induction J. Virol., August 1, 1999; 73(8): 6540 - 6550. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() F. Bunz, A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, J. P. Brown, J. M. Sedivy, K. W. Kinzler, and B. Vogelstein Requirement for p53 and p21 to Sustain G2 Arrest After DNA Damage Science, November 20, 1998; 282(5393): 1497 - 1501. [Abstract] [Full Text] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() R. E. Shackelford, C. L. Innes, S. O. Sieber, A. N. Heinloth, S. A. Leadon, and R. S. Paules The Ataxia telangiectasia Gene Product Is Required for Oxidative Stress-induced G1 and G2Checkpoint Function in Human Fibroblasts J. Biol. Chem., June 15, 2001; 276(24): 21951 - 21959. [Abstract] [Full Text] [PDF] ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() P. B. Deming, C. A. Cistulli, H. Zhao, P. R. Graves, H. Piwnica-Worms, R. S. Paules, C. S. Downes, and W. K. Kaufmann The human decatenation checkpoint PNAS, October 9, 2001; 98(21): 12044 - 12049. [Abstract] [Full Text] [PDF] ![]() |
![]() |
HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Research | Clinical Cancer Research |
Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
Molecular Cancer Research | Cell Growth & Differentiation |